Compound ID | 127
Class: Antibiofilm agent
| Agent Type: | Synthetic; Small molecule; Direct acting; Antibiofilm; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Fumarate reductase inhibitor |
| Target Pathogen: | Active against proteolytic species Porphyromonas gingivalis and Tannerella forsythia; indicated for chronic periodontitis |
| Institute where first reported: | Oral Health CRC, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Victoria, Australia |
| Year first mentioned: | 1975 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5281087 |
| Guide to Pharmacology: | oxantel |
| Citations: |
|